Why Check Point needs a Teva CEO

What good is a cash stockpile? ) is receiving credit of more than $1.5 billion from Israel's two largest banks, Bank Hapoalim and Bank Leumi, (to fund its acquisition of US generics rival Barr Pharmaceuticals Inc. (NYSE: BRL)). I have an original suggestion about this for Teva's newly appointed CFO Eyal Desheh. Take the loan from Check Point (Nasdaq: CHKP ), your last employer, since there is no chance of seeing any mega acquisitions like this while Gil Shwed remains in charge there, and the interest it is earning on the $1.3 billion in cash it currently has is miniscule. Two years ago, I wrote that Check Point would be doing itself a favor by giving a seat on its board to former Teva CEO Israel Makov and letting him make the company more enterprising by pushing for large mergers, since that is the only way to achieve the... [read full story]